THE GRAFT-VS-LEUKEMIA REACTION (GVLR) AND INTERLEUKIN-2 (IL-2) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - PRECLINICAL STUDIES

被引：0
|
作者：
KLOOSTERMAN, TC [1 ]
MARTENS, ACM [1 ]
VANBEKKUM, DW [1 ]
HAGENBEEK, A [1 ]
机构：
[1] TNO,INST APPL RADIOBIOL & IMMUNOL,RIJSWIJK,NETHERLANDS
来源：
EXPERIMENTAL HEMATOLOGY | 1992年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：721 / 721
页数：1
相关论文
共 50 条
  • [1] THE ROLE OF A GRAFT-VS-LEUKEMIA REACTION (GVLR) IN THE TREATMENT OF LEUKEMIA WITH BONE-MARROW TRANSPLANTATION (BMT)
    KLOOSTERMAN, TC
    TIELEMANS, MJC
    GAISER, JF
    MARTENS, ACM
    HOOGERBRUGGE, PM
    VANBEKKUM, DW
    HAGENBEEK, A
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 580 - 580
  • [2] PRODUCTION OF INTERLEUKIN-2 (IL-2) EARLY AFTER BONE-MARROW TRANSPLANTATION (BMT)
    SHERIDAN, JF
    DAVAKIS, LA
    CLOUSE, KA
    TUTSCHKA, PJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 325 - 325
  • [3] INTERLEUKIN-2 IN BONE-MARROW TRANSPLANTATION - PRECLINICAL STUDIES
    CHARAK, BS
    CHOUDHARY, GD
    TEFFT, M
    MAZUMDER, A
    BONE MARROW TRANSPLANTATION, 1992, 10 (02) : 103 - 111
  • [4] LYMPHOKINE RESPONSE (INTERLEUKIN-2) IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    SHERIDAN, JF
    DAVAKIS, L
    COPELAN, EA
    TUTSCHKA, PJ
    CLINICAL RESEARCH, 1986, 34 (04): : A921 - A921
  • [5] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) WITH INTERLEUKIN-2 (IL-2) - ACTIVATED BONE-MARROW
    CHARAK, B
    VERMA, U
    CAHILL, R
    MAZUMDER, A
    BLOOD, 1993, 82 (10) : A628 - A628
  • [6] INTERLEUKIN-2 (IL-2) RESTORATION OF DEFECTIVE INVITRO LYMPHOCYTE-PROLIFERATION FOLLOWING BONE-MARROW TRANSPLANTATION (BMT)
    LENARSKY, C
    WEINBERG, K
    PETERSEN, J
    PARKMAN, R
    PEDIATRIC RESEARCH, 1987, 21 (04) : A313 - A313
  • [7] PHASE-I TRIAL OF INTERLEUKIN-2 (IL-2) AFTER UNMODIFIED HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT)
    BENYUNES, MC
    SANDERS, JE
    BEACH, C
    THOMPSON, JA
    LINDGREN, C
    APPELBAUM, FR
    FEFER, A
    BLOOD, 1994, 84 (10) : A332 - A332
  • [8] Strong graft-vs-leukemia (GVL) effects of IL-2 activated natural killer cells given after bone marrow transplantation.
    Zeis, M
    Uharek, L
    Glass, B
    Dreger, P
    Steinmann, J
    Gassmann, W
    Schmitz, N
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 353 - 353
  • [9] INTERFERON-ALPHA AND INTERLEUKIN-2 AS TREATMENT FOR LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GIRALT, S
    OBRIEN, S
    TALPAZ, M
    VANBESIEN, K
    CHAN, KW
    RONDON, G
    ANDERSSON, B
    MEHRA, R
    KHOURI, I
    ESTEY, E
    CHAMPLIN, R
    CYTOKINES AND MOLECULAR THERAPY, 1995, 1 (02): : 115 - 122
  • [10] INHIBITION OF IL-2 PRODUCTION AFTER HUMAN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    AZOGUI, O
    GLUCKMAN, E
    FRADELIZI, D
    JOURNAL OF IMMUNOLOGY, 1983, 131 (03): : 1205 - 1208
12345